Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2025-04-22 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
立信会计师事务所（特殊普通合伙）关于深圳惠泰医疗器械股份有限公司2024年度募集资金存放与使用情况专项报告的鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" (Assurance Report) on the "募集资金存放与使用情况专项报告" (Special Report on the Deposit and Use of Raised Funds) for the year 2024 by Shenzhen Huitai Medical Device Co., Ltd. It includes detailed tables and explanations about the use and management of raised funds, references to regulatory guidelines from the China Securities Regulatory Commission, and audit procedures performed by certified accountants. The document is a standalone audit/assurance report focused on the raised funds usage, not a full annual report or interim financial report. It is not an announcement or a brief summary but a detailed verification report. This fits the category of Audit Report / Information (AR). The document length is substantial (15,000 characters), and it contains substantive content, not just a notice or certification letter. Therefore, the classification is AR with high confidence.
2025-04-22 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled "深圳惠泰医疗器械股份有限公司2024 年年度报告" which translates to "APT Medical Inc. 2024 Annual Report." It contains detailed financial data, management discussion and analysis, company overview, risk factors, governance, and audited financial statements. The document length is substantial (15,000 characters), and it includes comprehensive financial and operational information for the full fiscal year 2024. It also includes auditor's report references and signatures from company officers guaranteeing the accuracy of the report. These characteristics align with the definition of an Annual Report (10-K). There is no indication that this is merely an announcement or a summary; it is the full report itself. FY 2024
2025-04-22 Chinese
关于2025年度“提质增效重回报”行动方案
Management Reports Classification · 95% confidence The document is a detailed corporate communication from Shenzhen Huitai Medical Devices Co., Ltd. It outlines the company's strategic action plan for 2025, including operational focus, market development, R&D, financial management, governance, investor relations, and incentive mechanisms. The content is forward-looking and strategic, focusing on business plans, operational improvements, and investor communication rather than presenting financial statements or audit results. It does not contain quarterly or annual financial data or earnings highlights, nor is it a transcript of a call or a regulatory filing of voting results or director changes. The document is comprehensive and longer than 5,000 characters, indicating it is a substantive report rather than a brief announcement. Given the focus on management's explanation of business trends, strategy, and outlook, this fits best as a Management Report (MDA).
2025-04-22 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled "关联交易管理制度" which translates to "Related Party Transaction Management System". It details the company's policies, procedures, and governance regarding related party transactions, including definitions, pricing, approval authorities, and voting procedures. It references compliance with laws and stock exchange listing rules, but it is not a financial report, earnings release, or announcement. It is a governance document outlining internal rules and practices related to related party transactions. Therefore, it fits best under Governance Information (CGR). The document length (8075 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-04-22 Chinese
关于董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee evaluating the performance and supervision of the accounting firm for the fiscal year 2024. It discusses the audit firm's qualifications, the audit process, and the committee's oversight activities related to the 2024 annual audit. The document does not contain the actual financial statements or detailed audit results but rather a supervisory and evaluative report on the audit firm's work. It is not the full Annual Report (10-K) or the Audit Report (AR) itself but a report on the audit committee's oversight and the audit firm's performance. This type of document fits best under Audit Report / Information (AR), which includes standalone audit reports and results of internal or regulatory oversight related to audits, excluding full annual reports. The document length is 2164 characters, which is consistent with a detailed committee report rather than a brief announcement or certification. Therefore, the classification is AR with high confidence. FY 2024
2025-04-22 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司2024年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the 2024 annual special audit opinion on the deposit and use of raised funds by Shenzhen Huitai Medical Device Co., Ltd. It includes extensive financial data on the amount of funds raised, their usage, management, investment projects, changes in investment projects, and compliance with regulatory requirements. The document references regulatory guidelines related to the management and use of raised funds and includes an auditor's verification report. The content is focused on the management and use of capital raised through an IPO and subsequent fundraising, with detailed tables and explanations of fund usage, investment projects, and cash management. This type of document is a specialized audit or verification report on the use of capital raised, not a full annual report or earnings release. It is not a simple announcement or certification but a substantive report with financial data and audit opinions. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial aspects such as raised funds usage. FY 2024
2025-04-22 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.